
1. hum vaccin. 2011 feb;7(2):153-60. epub 2011 feb 1.

current experience school-located influenza vaccination programs the
united states: review medical literature.

hull hf(1), ambrose cs.

author information: 
(1)hf hull & associates, llc, st. paul, mn, usa. idepi@q.com

in united states, children 6 months 18 years age are
recommended vaccinated influenza annually. however, existing
pediatric immunization infrastructure capacity vaccinate a
high proportion children year. school-located influenza vaccination
(sliv) programs provide opportunity immunize large numbers school-age
children. reviewed medical literature order document current
u.s. experience benefit future sliv programs. published reports abstracts
for 36 sliv programs identified, spanned multiple years. the
programs immunized 70-128,228 students. programs vaccinated
40-50% students, coverage ranged 7-73%. higher percentages elementary 
students vaccinated compared middle high school students. while
many programs offered intranasal vaccine, several programs successfully
used intranasal injectable vaccines. faculty staff were
immunized programs uptake group varied considerably. students
were vaccinated quickly school hours. costs, reported, ranged from
approximately $20-$27 per dose delivered, including vaccine and
administration costs. greatest need future u.s. sliv program
implementation development financially sustainable model 
replicated annually national scale.

doi: 10.4161/hv.7.2.13668 
pmcid: pmc3166475
pmid: 21311217  [indexed medline]

